Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.

Takayuki GyotenDaniel MessroghliSoeren SchenkKristin RochorOliver GrimmigSoeren JustDirk Fritzsche

Published in: Open heart (2020)

In patients with HFrEF treated with MitraClip for FMR, moderate-to-severe FTR was an independent predictor of cardiac death within 1 year. To improve survival, additional therapy to residual FTR should be considered in early phase after MitraClip therapy.

Keyphrases

mitral valve
aortic valve
left ventricular
transcatheter aortic valve replacement
aortic stenosis
cell therapy
ejection fraction